Discontinuation report SANDOZ TOPIRAMATE TABLETS

Last updated on 2022-05-24 History
Report ID 161206
Drug Identification Number 02431807
Brand name SANDOZ TOPIRAMATE TABLETS
Common or Proper name TOPIRAMATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TOPIRAMATE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100FCT BO
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-05-24
Remaining supply date 2022-05-24
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-05-24 French Compare
v1 2022-05-24 English Compare

Showing 1 to 2 of 2